Skip to main content

ERRATUM article

Front. Oncol., 07 December 2023
Sec. Pediatric Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1339187

Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma

This article is an erratum on:

  1. PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma

By Al-Ghazzawi K, Wessolly M, Dalbah S, Ketteler P, Kiefer T, Bechrakis N, Leyla J, Ting S, Biewald E and Mairinger FD (2023) Front. Oncol. 13:1144951. doi: 10.3389/fonc.2023.1144951

Due to a production error, section 3.2 Anaplastic grade included two empty subsections: 3.2.1 Undifferentiated retinoblastoma and 3.2.2 Differentiated retinoblastoma. These subsections have been removed.

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: retinoblastoma - epigenetics, retinoblastoma, PDGF = platelet-derived growth factor, MAPK/ERK2 pathway 1, pediatric cancer and oncology, biomarkers, targeted therapy, growth factors (angiogenesis factors)

Citation: Frontiers Production Office (2023) Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Front. Oncol. 13:1339187. doi: 10.3389/fonc.2023.1339187

Received: 15 November 2023; Accepted: 15 November 2023;
Published: 07 December 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.